Analyst firms · Oppenheimer · AUPH
Oppenheimer AUPH price target and rating history
Aurinia Pharmaceuticals Inc (AUPH) · Health Care
Oppenheimer rates Aurinia Pharmaceuticals Inc (AUPH) Perform with a $31 price target, as of its latest action on Nov 4, 2022. It has published 4 rating actions on AUPH since October 2021, including 1 upgrade and 2 downgrades.
- Current rating
- Perform
- Price target
- $31
- Median target, all firms
- Too few
- Actions on AUPH
- 4
Oppenheimer price target on AUPH
Every Oppenheimer rating on AUPH
- Nov 4, 2022
- Dec 10, 2021
- Nov 4, 2021
- Oct 28, 2021
Questions about Oppenheimer and AUPH
- What is Oppenheimer's price target for AUPH?
- Oppenheimer's latest stated price target for Aurinia Pharmaceuticals Inc (AUPH) is $31, from its action on Dec 10, 2021.
- What is Oppenheimer's rating on AUPH?
- Oppenheimer rates AUPH Perform, a neutral rating, as of Nov 4, 2022.
- When did Oppenheimer last change its view on AUPH?
- On Nov 4, 2022, Oppenheimer downgrades to Perform from Outperform.
More AUPH rating histories
All Oppenheimer ratingsAUPH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.